ClinicalTrials.gg
Drug

Ixazomib clinical trials

Also written MLN9708, Ninlaro and MLN2238.

studies test it
125
open now
3
in phase 3
10
first study started
2009
Related medicines add 1 study

Counted the way a researcher would: Ixazomib with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses ixazomib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ixazomib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Nov 2015 · NINLARO · NDA 208462 (FDA, Drugs@FDA)
European Union
21 Nov 2016 · Ninlaro · EMEA/H/C/003844 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ixazomib
82
Ixazomib Citrate
30
proteasome inhibitor MLN9708
3
Ixazomib 4 MG
2

Brand

Ninlaro
46

Development codes

MLN9708
70
MLN2238
5

Studies by the year they started

125 studies that test it; most in 2015 (20)

Studies that test ixazomib, by start year
YearStudies
20094
20101
20114
20127
20135
201416
201520
201614
201712
201815
201914
20207
20211
20223
20231
20261

Who runs them

Industry 32 · Other 93

Millennium Pharmaceuticals, Inc. (19) · Takeda (11) · M.D. Anderson Cancer Center (9) · Mayo Clinic (9) · National Cancer Institute (NCI) (4) · Emory University (4) · Memorial Sloan Kettering Cancer Center (3) · Fred Hutchinson Cancer Center (2)

Often tested with

Tested in the same studies.

Dexamethasone (34) · Lenalidomide (17) · Daratumumab (11) · Pomalidomide (8) · Rituximab (4) · Venetoclax (3) · Bortezomib (2) · Ibrutinib (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test ixazomib.

Studies

Open first, then newest update. How each study uses ixazomib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 125

See all 125 studies that test ixazomib →

Given beside what is tested · 16 — ixazomib is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with ixazomib

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call ixazomib · ClinicalTrials.gg INT005598

  • MeSH (NLM) C548400ixazomibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 71050168A2IXAZOMIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1723735Confirmed FDA, Wikidata
  • Wikidata Q20948663ixazomibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C97940IxazomibOne source FDA
  • DrugBank DB09570One source Wikidata

Also registered as ixazomib citrate (UNII 46CWK97Z3K · RxNorm 1723734).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.